A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia

Vaccine
Volume 39, Issue 44 Pages 6451-6564 (22 October 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/44

 

Research article Open access
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia
Eddy Fadlyana, Kusnandi Rusmil, Rodman Tarigan, Andri Reza Rahmadi, … Cissy B. Kartasasmita
Pages 6520-6528